advertisement
Cancers 8
Showing records 1 to 8 | Display all abstracts in Cancers98822 The Incidence Risk for Primary Glaucoma and Its Subtypes following Chronic Exposure to Ionizing Radiation in the Russian Cohort of Mayak Nuclear Workers
Azizova TV
Cancers 2022; 14:
99226 Hypofractionated Whole Breast Irradiation and Boost-IOERT in Early Stage Breast Cancer (HIOB): First Clinical Results of a Prospective Multicenter Trial (NCT01343459)
Fastner G
Cancers 2022; 14:
98822 The Incidence Risk for Primary Glaucoma and Its Subtypes following Chronic Exposure to Ionizing Radiation in the Russian Cohort of Mayak Nuclear Workers
Bragin EV
Cancers 2022; 14:
99226 Hypofractionated Whole Breast Irradiation and Boost-IOERT in Early Stage Breast Cancer (HIOB): First Clinical Results of a Prospective Multicenter Trial (NCT01343459)
Reitsamer R; Gaisberger C
Cancers 2022; 14:
98822 The Incidence Risk for Primary Glaucoma and Its Subtypes following Chronic Exposure to Ionizing Radiation in the Russian Cohort of Mayak Nuclear Workers
Bannikova MV; Hamada N
Cancers 2022; 14:
99226 Hypofractionated Whole Breast Irradiation and Boost-IOERT in Early Stage Breast Cancer (HIOB): First Clinical Results of a Prospective Multicenter Trial (NCT01343459)
Hitzl W
Cancers 2022; 14:
98822 The Incidence Risk for Primary Glaucoma and Its Subtypes following Chronic Exposure to Ionizing Radiation in the Russian Cohort of Mayak Nuclear Workers
Grigoryeva ES
Cancers 2022; 14:
99226 Hypofractionated Whole Breast Irradiation and Boost-IOERT in Early Stage Breast Cancer (HIOB): First Clinical Results of a Prospective Multicenter Trial (NCT01343459)
Urbański B; Murawa D; Matuschek C; Budach W; Ciabattoni A; Reiland J; Molnar M; Vidali C; Schumacher C; Sedlmayer F; On Behalf Of The Hiob Trialist Group
Cancers 2022; 14:
